PharmaCielo Ltd. (PCLO.V)

CAD 0.09

(-10.0%)

Revenue Summary of PharmaCielo Ltd.

  • PharmaCielo Ltd.'s latest annual revenue in 2023 was 1.54 Million CAD , down -70.96% from previous year.
  • PharmaCielo Ltd.'s latest quarterly revenue in 2024 Q2 was 783.68 Thousand CAD , up 226.17% from previous quarter.
  • PharmaCielo Ltd. reported a annual revenue of 5.3 Million CAD in annual revenue 2022, up 172.93% from previous year.
  • PharmaCielo Ltd. reported a annual revenue of 1.94 Million CAD in annual revenue 2021, down -26.71% from previous year.
  • PharmaCielo Ltd. reported a quarterly revenue of 240.26 Thousand CAD for 2024 Q1, down -1.54% from previous quarter.
  • PharmaCielo Ltd. reported a quarterly revenue of 244.02 Thousand CAD for 2023 Q4, down -30.61% from previous quarter.

Annual Revenue Chart of PharmaCielo Ltd. (2023 - 2017)

Historical Annual Revenue of PharmaCielo Ltd. (2023 - 2017)

Year Revenue Revenue Growth
2023 1.54 Million CAD -70.96%
2022 5.3 Million CAD 172.93%
2021 1.94 Million CAD -26.71%
2020 2.65 Million CAD 237.26%
2019 786.9 Thousand CAD 0.0%
2018 - CAD 0.0%
2017 - CAD 0.0%

Peer Revenue Comparison of PharmaCielo Ltd.

Name Revenue Revenue Difference
Aequus Pharmaceuticals Inc. 254.89 Thousand CAD -504.854%
CanadaBis Capital Inc. 22.22 Million CAD 93.062%
Decibel Cannabis Company Inc. 115.95 Million CAD 98.67%
Delivra Health Brands Inc. 12.37 Million CAD 87.544%
Entourage Health Corp. 40.71 Million CAD 96.213%
Lifeist Wellness Inc. 21.65 Million CAD 92.882%
Cannara Biotech Inc. 57.26 Million CAD 97.307%
Medicure Inc. 21.69 Million CAD 92.893%
Rubicon Organics Inc. 40.11 Million CAD 96.157%
BioSyent Inc. 31.59 Million CAD 95.12%
Voyageur Pharmaceuticals Ltd. - CAD -Infinity%